Monday, December 7, 2020

Bharat Biotech likely to apply for emergency use approval for coronavirus COVAXIN vaccine this week

Bharat Biotech had announced the commencement of Phase III trials of its coronavirus COVAXIN vaccine on November 16. 

from Zee News :Zee News - Health https://ift.tt/37FJTAG
via IFTTT

No comments:

Post a Comment

Experts reveal that cardiovascular diseases are the cause of nearly 28% of all deaths in India

Heart diseases are becoming one of the biggest health problems in India, causing almost 28% of all deaths. Experts highlight the need of he...